Studies show that physicians have to pay approximately $1 million to deal with the post-payment integrity audits. It is concerning, especially, when we are trying to minimize healthcare expenses.
A study by scientists in a UK university has shown the scale of the prevalence of a condition that can lead to various cardiometabolic diseases.
The study published in the Annals of Internal Medicine journal on Tuesday (January 4) has prompted calls for changes to healthcare policy after researchers revealed, for the first time, the scale of the impact of the condition associated with benign tumours that can lead to type 2 diabetes and high blood pressure.
Up to 10 per cent of adults have a benign tumour, or lump, known as an 'adrenal incidentaloma' in their adrenal glands which can be associated with the overproduction of hormones including the stress steroid hormone cortisol that can lead to type 2 diabetes and high blood pressure.
Previous small studies suggested that one in three adrenal incidentalomas produce excess cortisol, a condition called mild autonomous cortisol secretion (MACS).
An international research team led by the University of Birmingham carried out the largest ever prospective study of over 1,305 patients with adrenal incidentalomas to assess their risk of high blood pressure and type 2 diabetes and their cortisol production by comparing patients with and without MACS.
Department of Health and Social Care (DHSC) has issued a supply notification for Varicella vaccine (live) powder and solvent for suspension/solution for
injection 0.5ml vials (Varivax and Varilrix) until mid-October.
AAH have put quotas in place for GPs to limit the ordering of Varilrix and safeguard supplies during this shortage. To override this quota or obtain stock in any
other primary care setting (including community pharmacy) a prescription will be required.
To obtain stock through the prescription validation system pharmacy will have to contact AAH Quota Management Customer Care team:
Online https://www.aah.co.uk/s/quotarequest or by logging into AAH Point https://www.aah.co.uk/s/signin then choose Additional Services and select Quotas.
The pharmacy should follow the steps and fill in the required information including their email address.
The pharmacy can also call: 0344 561 8899 and select option 3 (quota)
The pharmacy will need to have the prescription details available
The AAH team will review the request and follow the guidance provided below to validate the prescription and approve the order.
Kailash Hospital is one of the best hospital in East Delhi offering a wide range of medical services and surgical treatment. We are known for providing effective long term treatment, preventing recurrences, non-invasive treatment & fast recovery.
The Royal Pharmaceutical Society (RPS)'s new research (YouGov poll) revealed that one in five of UK adults (19%) keep their medicines in the bathroom.
The research revealed, "Almost one in two (45%) of UK adult keep their medicines in the kitchen, which could also cause problems.
RPS Chief Scientist Professor Parastou Donyai said: "It's important to store your medicines in the right place as this could affect how they work.
"Medicines should be stored in a cool, dry place and are particularly affected by heat and moisture. Keeping your medicines in the same place as where you have
baths and showers could make your medicines less effective or spoil them.
"Instead keep your medicines in another room, for example your bedroom or if you keep them in the kitchen, make sure this is in a kitchen cabinet, away from sources
of heat such as the hob, oven or windowsill. If you have small children or pets in the home, always make sure your medicines are kept in a lockable storage box
somewhere out of their reach and sight."
The Mentholatum Company is shaking up the dry eye market with a clinically proven, world-leading advanced dry eye relief formulation. Rohto Dry Aid relieves
EIGHT symptoms of dry eye and helps hydrate, protect and restore the tear film.
Elvy Mardjono, senior brand manager for Rohto Dry Aid, says: "Rohto Dry Aid, with its Tearshield Technology™ acts fast, is non-blurry and delivers soothing relief
for up to 12 hours."
Rohto Dry Aid's Tearshield Technology™ formulation is kind to the eyes and designed to mimic the properties of the natural tear film, providing the protection and
hydration required to tackle dry spots and restore all layers of the natural tear film.
Yes, it is completely fine to opt In-vitro fertilization when suffering from infertility, It is the most popular method accepted all around the globe, and only due to this treatment method many couples have been able to become parents.
The most generic question that interrupts every couple's mind is when the IVF process should be done. Is it done when one fails to conceive, or is it done when one suffers from secondary infertility.
Diabetes drugs that also promote weight loss such as Novo Nordisk's Ozempic, becoming a darling of celebrities and investors, are being studied to tackle some
of the most difficult-to-treat brain disorders, including Alzheimer's disease.
Diabetes regimens, from Ozempic to old mainstays like insulin and metformin, appear to address several different aspects of the metabolic system implicated in
Alzheimer's disease, including a protein called amyloid and inflammation, researchers say.
The hope is that improving glucose utilisation and tamping down inflammation in the entire body - including the brain - could slow progression of debilitating
diseases like Alzheimer's and Parkinson's.
Several scientists interviewed by Reuters news agency pointed to mounting research supporting testing diabetes drugs against neurodegenerative diseases.
Results are years away and success uncertain. But interest has been buoyed by recent positive data on Alzheimer's drugs developed by Eisai with partner Biogen and
by Eli Lilly demonstrating that removing sticky amyloid plaques accumulated in the brain can slow cognition decline caused by the fatal mind-wasting disease.
Those successes followed decades of futility that had left many questioning the validity of the amyloid theory behind most experimental Alzheimer's drugs.
One in eight people who were hospitalised with Covid-19 between May 2020 and March 2021 were later diagnosed with myocarditis, according to major new research
into the clinical long-term effects of coronavirus.
The largest study of its kind to date was led by the University of Glasgow in collaboration with NHS Greater Glasgow and Clyde (NHS GGC), and followed for one year, in real time, 159 patients after they were hospitalised with Covid-19.
The study also looked at why some patients suffer long-term ill health after hospitalisation with Covid-19. Until now it has been speculated that previous underlying
health conditions may be linked to the severity of post-Covid long-term effects.
However, this new study suggests that it is the severity of the infection itself which is most closely correlated to the severity of a patient's long-Covid symptoms, rather than pre-existing health problems.
Hospitalisation with Covid-19 was found to cause a number of long-term health problems.
Researchers found one in eight patients hospitalised with Covid-19 have heart inflammation, while inflammation across the body and damage to the other organs such as the kidneys was also common.
The NHS is going to roll out a revolutionary 30-minute treatment for advanced womb cancer for women across England.
The drug, called Dostarlimab, would benefit around 100 women with advanced and often incurable endometrial cancer every year after the NHS agreed early access to the treatment through the Cancer Drugs Fund.
It works by attaching to a specific protein on the surface of the cancer cells, helping the immune system to detect and attack it.
The treatment takes just 30 minutes to administer through the blood stream every three weeks over a 12-week period.
The move is in line with the NHS Long Term Plan which aims to provide the latest cutting-edge treatments and therapies for patients.
A new report, published by the Office of National Statistics (ONS), has revealed worrying statistics about the mental health of children and young people
in England.
The report is based on NHS survey on Mental Health of Children and Young People in England 2023, which showed that one in five children and young individuals
aged eight to 25 were grappling with probable mental disorders.
The report highlighted that 20.3 per cent of eight to 16-year-olds showed signs of mental distress in 2023. Among 17 to 19-year-olds, the proportion rose to
23.3 per cent, while in 20 to 25-year-olds, it stood at 21.7 per cent.
The rates of probable mental disorders were similar for boys and girls, while for 17- to 25-year-olds, rates were twice as high for young women than young men.
A recent study, conducted by CBD experts at Brown's CBD, unveiled Dundee as the UK's leading CBD hotspot, with an average monthly search volume
of 530.29 per 100,000 residents, sparking a surge of interest in natural wellness solutions.
New research analysed search volume data across UK cities for CBD-related terms, reflecting a staggering 1100% increase in searches for 'what is CBD' over
the last decade.
Following Dundee, Brighton secures the second spot in the rankings with an average monthly search volume of 530.08 per 100,000 residents for CBD related
terms, closely trailed by St. Albans in third place.
Other notable cities making the top ranks include Gloucester, Hereford, and Bath, indicating a widespread curiosity about CBD products and their purported
health benefits.
Pharmadoctor, a company which provides clinical service packages to pharmacists, has announced the launch of the UK's first private Covid vaccination
service via its nationwide network of partner community pharmacies.
For the first time, people who are eligible for the Covid-19 vaccine (those aged 12 years and over) will be able to get the shots from their local independent
pharmacy by paying as little as £45 per jab, the company said.
The delivery of the new service is expected to start by 1st April at the latest by "thousands of pharmacists" using the Pharmadoctor eTool.
To encourage pharmacists to sign up early to provide the service, the company is offering its package at half-price until 31st March.
The latest findings from the National Cancer Patient Experience Survey 2022 by QualityWatch, a joint programme with the Nuffield Trust and the Health
Foundation shed light on concerning disparities faced by ethnic minority communities in the UK healthcare system.
Despite strides in cancer care, the survey highlights persistent challenges in easy and equitable access to timely diagnosis and quality communication,
particularly for individuals from Mixed, Black, or Asian backgrounds.
Key insights from the survey underscored that individuals from ethnic minority groups often require a higher number of interactions with healthcare professionals
before receiving a cancer diagnosis.
Notably, one in three people from Mixed, Black, or Asian ethnicities needed three or more visits to a GP practice, compared to the average of one in five across
the population.
These delays in diagnosis can have significant implications for treatment outcomes and overall patient experience.
Moreover, the survey revealed concerning trends regarding the quality of communication following a cancer diagnosis among ethnic minority patients.